Neurocognitive effects experienced by advanced cancer survivors after immunotherapy

Pers / media: !!Research

Description

Interview with Medimix Oncology at the ESMO Congress 2023 in Madrid.

https://www.linkedin.com/posts/medimixbelgium_medimix-esmo2023-cancersurvivorship-activity-7136340526676500480-ZR7L/?utm_source=share&utm_medium=member_desktop

Periode1 dec 2023

Mediabijdrages

1

Mediabijdrages